CryoCloud is a cloud-native platform that aims to accelerate protein structure determination using cryoEM data analysis. The company's slogan "Accelerating protein structure determination" encapsulates their mission to make cryo-EM more accessible, affordable, and automated, while eliminating the need for hardware and software setup & maintenance. By providing solutions for live data uploads and end-to-end cryoEM data analysis via a web-app, CryoCloud removes entry barriers for new researchers and accelerates analysis for everybody without the need for installation or setup. This is further facilitated by a 30-day free trial, enabling users to get started on their data analysis seamlessly. The company operates within the biotechnology and cloud infrastructure industries and is based in The Netherlands. In its last investment round on 31 October 2023, CryoCloud secured €500.00K in a Pre Seed Round investment from Nina Ventures, ROM Utrecht Region, and Utrecht Health Seed Fund. This injection of funds will likely contribute to CryoCloud's efforts in streamlining cryoEM data analysis and advancing their mission to revolutionize protein structure determination within the biotechnology sector.